Please use this identifier to cite or link to this item:
|Title:||Calcium, calcium antagonism, atherosclerosis, and ischemia.|
|Authors:||Nayler, W G|
|Affiliation:||Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia.|
|Citation:||Journal of Cardiovascular Pharmacology; 19 Suppl 2(): S17-21|
|Abstract:||Calcium is a ubiquitous cation involved in a wide variety of physiological processes. Normally, cytosolic calcium is maintained within narrow limits but under certain conditions the levels rise--either because of excess calcium entry, internal release, or failure of the extrusion mechanisms. Such conditions include hypertension and myocardial ischemia. Calcium ions are also involved in the formation of atherosclerotic lesions. Hypertension, ischemic heart disease, and atherosclerosis are all amenable to calcium antagonist therapy. The efficacy of this class of drugs in the management of such a wide spectrum of disorders is in accord with the central role played by calcium in the etiology of these disorders. To some extent, however, the disorders are interrelated, with hypertension being a major risk factors for ischemic heart disease and atherosclerosis.|
|Internal ID Number:||1377299|
Arteriosclerosis.drug therapy.prevention & control
Coronary Disease.drug therapy.metabolism
Rats, Inbred SHR
Rats, Inbred WKY
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.